| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |